share_log
Moomoo 24/7 ·  04/23 07:30

Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of Lsta1 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Lisata Therapeutics和齊魯製藥宣佈齊魯在中國開展的針對轉移性胰腺導管腺癌患者Lsta1的2期試驗中首位患者接受治療

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論